GLH — Global Health Income Statement
0.000.00%
Last trade - 00:00
- AU$5.80m
- AU$4.85m
- AU$7.82m
- 48
- 48
- 14
- 31
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.52 | 6.26 | 7.03 | 6.54 | 7.82 |
Cost of Revenue | |||||
Gross Profit | 3.96 | 5 | 5.38 | 4.86 | 6.25 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 6.36 | 6.39 | 7.6 | 8.51 | 15.4 |
Operating Profit | -0.833 | -0.132 | -0.564 | -1.98 | -7.63 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.972 | -0.242 | -0.626 | -2.01 | -7.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.3 | -0.06 | -0.488 | -2.05 | -8.05 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.3 | -0.06 | -0.488 | -2.05 | -8.05 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.3 | -0.06 | -0.488 | -2.05 | -8.05 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.036 | -0.002 | -0.003 | -0.037 | -0.096 |